Corpus Intelligence IC Memo — FRANKLIN MEMORIAL HOSPITAL 2026-04-26 04:58 UTC
IC Memo — FRANKLIN MEMORIAL HOSPITAL
Investment Committee Memorandum | ME | 46 beds | Grade C | EBITDA uplift $7.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FRANKLIN MEMORIAL HOSPITAL

CCN 200037 | FRANKLIN, ME | 46 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

FRANKLIN MEMORIAL HOSPITAL is a 46-bed under-performing / distressed in FRANKLIN, ME with $103.4M in net patient revenue and a -17.3% operating margin. The hospital serves a payer mix of 22.9% Medicare, 11.0% Medicaid, and 66.1% commercial.

Thesis: Turnaround. Our ML models identify $7.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -17.3% to -10.0% (+736bps).

Net Revenue HCRIS$103.4M
Current EBITDA COMPUTED$-17.9M
Operating Margin COMPUTED-17.3%
Occupancy HCRIS50.3%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS41.7%
Distress Probability ML49.1%

2. Market Context & Competitive Position

38
ME Hospitals
-8.3%
State Median Margin
28
Comparable Hospitals

ME has 38 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -17.3% places it below the state median. Among 28 size-comparable peers (23-92 beds), the median margin is -5.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (23-92), prioritizing same-state peers. 28 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FRANKLIN MEMORIAL HOSPITAL (Target)ME46$103.4M-17.3%
MERCY HOSPITALME77$240.0M-11.6%
YORK HOSPITALME54$197.1M-3.6%
PENOBSCOT BAY MEDICAL CENTERME81$171.6M-21.7%
REDINGTON-FAIRVIEW GENERAL HOSME25$135.4M-3.6%
THE AROOSTOOK MEDICAL CENTERME34$134.8M-23.5%
LINCOLNHEALTHME25$116.8M-0.9%
WALDO COUNTY GENERAL HOSPITALME25$115.4M-6.4%
STEPHENS MEMORIAL HOSPITAL - CME25$100.5M4.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.2M+210bp18mo
Cost to Collect4.5%2.5%$2.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$66K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.2M
Cost to Collect
$2.1M
Denial Rate Reduction
$2.0M
A/R Days Reduction
$1.3M
Clean Claim Rate
$66K
Total EBITDA Uplift$7.6M
Current EBITDA$-17.9M
+ RCM Uplift+$7.6M
Pro Forma EBITDA$-10.3M
Current Margin-17.3%
Pro Forma Margin-10.0%
WC Released (1x)$4.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-27.5M$-42.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-27.5M$-55.2M0.00x-100.0%
Bull Case9.0x11.0x$-24.8M$-39.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-24.8M$-49.9M0.00x-100.0%
Bear Case11.0x10.0x$-30.3M$-71.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-30.3M$-88.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 28 hospitals with 23-92 beds
  • Same-state prioritization (n=29)
  • Comp margins: P25=-10.6% / P50=-5.2% / P75=0.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.